1.0 link 58597 http://www.huffingtonpost.com/trevor-butterworth/so-what-did-we-learn-from_b_58597.html If you have been following the trials and tribulations of the diabetes drug Avandia, you might be surprised to have learned that after all the grim prognostication in the media, all the haughty criticism of the state of drug regulation by newspaper op-eds, the warnings of death-tolls exceeding 9/11, and of medication that was useless for all but lining Big Pharma's coffers, the expert panel commissioned by the Food and Drug Administration to investigate whether to pull the drug from...

]]> 2008-03-28T02:47:00-04:00